Skip to main content
OpenTrials
Completed

NCT Number: NCT04345536

Prospective Quality Register of Patients With Confirmed Covid-19 at Oslo University Hospital

Covid-19 is a recently emerging infectious disease with a very large impact on health care world-wide. The disease is still poorly described. It is an urgent need for better clinical characteristics. A prospective, quality register is therefore established for increasing the knowledge about the disease, the covid patients and the prognosis.

Completed

Looking for future studies?

Notify Me

Key information

About this study

All patient hospitalized at Oslo University Hospital, Ullevål, is prospectively registered in the approved quality register. Background, clinical and paraclinical data is harvested and registered, as well as treatment and mortality.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Confirmed covid-19
  • hospitalized

Exclusion criteria

  • None

Treatment and study plan

Primary outcomes

  1. Mortality

    Time frame: 3 month

    Mortality in hospitalized covid patients

  2. Severe disease

    Time frame: 2 weeks

    Number of patients with severe disease

Sponsors and collaborators

Lead sponsor

Oslo University Hospital

Other

Registry information

Acronym: CovidRegOUH

Important dates

Study start
2020
Primary completion
2022
Study completion
2023
First posted
Apr 14, 2020
Registry last updated
Nov 14, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.